Syndicate This week's upcoming IPO's and secondary offerings

Week of September 18 to September 22, 2024

This Day's Priced Deals: September 20th, 2017

Symbol

Issuer

Type

Price

Managers

BSTI

Best Inc
Best Inc
IPO
Priced: $10.00
45M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, Credit Suisse, Goldman Sachs, JPMorgan & Deutsche Bank, CLSA, KeyBanc, Oppenheimer, Stifel

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CELC

Celcuity
Celcuity
IPO
Priced: $9.50
2.4M
Craig-Hallum

Pricing after close
Deal analysis and details

Managers: Craig-Hallum

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
DESP

Despegar.com
Despegar.com
IPO
Priced: $26.00
12.7M
Morgan Stanley & Citi,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Morgan Stanley & Citi, Itau BBA, UBS, TD Cowen, KeyBanc

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
KRYS

Krystal Biotech
Krystal Biotech
IPO
Priced: $10.00
3.96M
Ladenburg

Pricing after close
Deal analysis and details

Managers: Ladenburg

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ZLAB

Zai Lab
Zai Lab
IPO
Priced: $18.00
8M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, Citi & Leerink

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
DSKE

Daseke
Daseke
Secondary
Priced: $12.00
5.3M
Stifel & TD Cowen,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Stifel & TD Cowen, Craig-Hallum, Northland

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
NBRV

Nabriva Therapeutics
Nabriva Therapeutics
Secondary
Priced: $8.50
9.41M
Morgan Stanley & BofA,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Morgan Stanley & BofA, Truist, Needham, Wedbush

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
BBU

Brookfield Business Partners
Brookfield Business Partners
Spot Secondary
Priced: $30.00
6.67M
TD Securities,...

Pricing after close
Deal analysis and details

Managers: TD Securities, Citi, CIBC, Morgan Stanley & RBC Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
FWONK

Liberty Formula One
Liberty Formula One
Spot Secondary
Priced: $37.40
17.7M
Goldman Sachs

Pricing after close
Deal analysis and details

Managers: Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Deals to be Priced

09/21 - Thursday

Symbol

Issuer

Type

Price

Managers

ONCE

Spark Therapeutics
Spark Therapeutics
Block Trade
$87.10
1M
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Priced Deals

09/18 - Monday

Symbol

Issuer

Type

Price

Managers

ALDX

Aldeyra
Aldeyra
Spot Secondary
Priced: $7.25
3.45M
Cantor Fitzgerald,...

Pricing after close
Deal analysis and details

Managers: Cantor Fitzgerald, Laidlaw

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MDWD

MediWound
MediWound
Spot Secondary
Priced: $5.00
4.4M
TD Cowen & Wells Fargo,...

Pricing after close
Deal analysis and details

Managers: TD Cowen & Wells Fargo, Oppenheimer, Truist

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

09/19 - Tuesday

Symbol

Issuer

Type

Price

Managers

BSTI

Best Inc
Best Inc
IPO
Priced: $10.00
45M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, Credit Suisse, Goldman Sachs, JPMorgan & Deutsche Bank, CLSA, KeyBanc, Oppenheimer, Stifel

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CELC

Celcuity
Celcuity
IPO
Priced: $9.50
2.4M
Craig-Hallum

Pricing after close
Deal analysis and details

Managers: Craig-Hallum

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
DESP

Despegar.com
Despegar.com
IPO
Priced: $26.00
12.7M
Morgan Stanley & Citi,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Morgan Stanley & Citi, Itau BBA, UBS, TD Cowen, KeyBanc

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
KRYS

Krystal Biotech
Krystal Biotech
IPO
Priced: $10.00
3.96M
Ladenburg

Pricing after close
Deal analysis and details

Managers: Ladenburg

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ZLAB

Zai Lab
Zai Lab
IPO
Priced: $18.00
8M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, Citi & Leerink

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
DSKE

Daseke
Daseke
Secondary
Priced: $12.00
5.3M
Stifel & TD Cowen,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Stifel & TD Cowen, Craig-Hallum, Northland

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
NBRV

Nabriva Therapeutics
Nabriva Therapeutics
Secondary
Priced: $8.50
9.41M
Morgan Stanley & BofA,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Morgan Stanley & BofA, Truist, Needham, Wedbush

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
BBU

Brookfield Business Partners
Brookfield Business Partners
Spot Secondary
Priced: $30.00
6.67M
TD Securities,...

Pricing after close
Deal analysis and details

Managers: TD Securities, Citi, CIBC, Morgan Stanley & RBC Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
FWONK

Liberty Formula One
Liberty Formula One
Spot Secondary
Priced: $37.40
17.7M
Goldman Sachs

Pricing after close
Deal analysis and details

Managers: Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

09/20 - Wednesday

Symbol

Issuer

Type

Price

Managers

OMP

Oasis Midstream Partners
Oasis Midstream Partners
IPO
Priced: $17.00
7.5M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley, Citi & Wells Fargo, Credit Suisse, Deutsche Bank, Goldman Sachs, JPMorgan, RBC Capital, BOKF, BBNT, BBVA, BTIG, COSC, CIBC, COMC, HEIK, Iberia, INGC, RICE, Raymond James, REGN, Simmons, TPH&Co.

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
BECN

Beacon Roofing
Beacon Roofing
Secondary
Priced: $47.50
6.325M
BofA,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: BofA, RBC Capital & Truist, Baird, CL King, Raymond James, GHSC

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IOVA

Iovance Biotherapeutics
Iovance Biotherapeutics
Secondary
Priced: $6.50
7.69M
Jefferies & Wells Fargo,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Jefferies & Wells Fargo, Oppenheimer

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
XLRN

Acceleron
Acceleron
Secondary
Priced: $37.00
5.405M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, Citi & Leerink

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
VEON

Veon
Veon
Spot Secondary
Priced: $4.15
90M
Citi & Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Citi & Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

09/21 - Thursday

Symbol

Issuer

Type

Price

Managers

SECO

Seeco Holding
Seeco Holding
IPO
Priced: $13.00
8.5M
Jefferies,...

Pricing after close
Deal analysis and details

Managers: Jefferies, BNP Paribas

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
JUNO

Juno Therapeutics
Juno Therapeutics
Secondary
Priced: $41.00
6.1M
Morgan Stanley & JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Morgan Stanley & JPMorgan, Barclays, Wells Fargo, Raymond James, Leerink, Wedbush

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access